IL95890A0 - Hiv related peptides - Google Patents

Hiv related peptides

Info

Publication number
IL95890A0
IL95890A0 IL95890A IL9589090A IL95890A0 IL 95890 A0 IL95890 A0 IL 95890A0 IL 95890 A IL95890 A IL 95890A IL 9589090 A IL9589090 A IL 9589090A IL 95890 A0 IL95890 A0 IL 95890A0
Authority
IL
Israel
Prior art keywords
hiv
terminal
related peptides
hiv related
peptides
Prior art date
Application number
IL95890A
Other languages
English (en)
Original Assignee
Univ George Washington
Viral Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23666609&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL95890(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ George Washington, Viral Technologies Inc filed Critical Univ George Washington
Publication of IL95890A0 publication Critical patent/IL95890A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16211Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL95890A 1989-10-12 1990-10-03 Hiv related peptides IL95890A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US42046989A 1989-10-12 1989-10-12

Publications (1)

Publication Number Publication Date
IL95890A0 true IL95890A0 (en) 1991-07-18

Family

ID=23666609

Family Applications (1)

Application Number Title Priority Date Filing Date
IL95890A IL95890A0 (en) 1989-10-12 1990-10-03 Hiv related peptides

Country Status (17)

Country Link
EP (3) EP0620010A1 (es)
JP (1) JPH03209398A (es)
KR (1) KR910007962A (es)
CN (1) CN1052310A (es)
AT (1) ATE119166T1 (es)
AU (1) AU6393990A (es)
CA (1) CA2027455A1 (es)
DE (1) DE69017352T2 (es)
DK (1) DK0426314T3 (es)
ES (1) ES2071038T3 (es)
GB (1) GB2236754A (es)
GR (1) GR3015244T3 (es)
HU (1) HUT55035A (es)
IE (1) IE67533B1 (es)
IL (1) IL95890A0 (es)
NZ (1) NZ235538A (es)
ZA (1) ZA907944B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4039925A1 (de) * 1990-12-14 1992-06-17 Behringwerke Ag Ausgewaehlte peptide des gruppenspezifischen antigens (gag) von humanem immundefizienzvirus (hiv), ihre herstellung und verwendung
FR2734281B1 (fr) * 1995-05-18 1997-07-25 Commissariat Energie Atomique Fragments d'acide nucleique derives du genome du virus vih-1, peptides correspondants et leurs applications en tant que reactifs d'evaluation du risque de transmission materno-foetale du vih-1
US6103239A (en) * 1996-08-09 2000-08-15 Cel-Sci Corporation Modified HGP-30 heteroconjugates, compositions and methods of use
NO314588B1 (no) 2000-09-04 2003-04-14 Bionor Immuno As HIV-peptider, antigener, vaksinesammensetning, immunoassay- testsett og en fremgangsmåte for å påvise antistoffer indusert av HIV
EP1417222B1 (en) * 2001-08-07 2010-08-18 Medestea Internazionale S.p.A. Isolated polypeptides based on the neutralizing epitope of the p17 protein of hiv useful as vaccines, and neutralizing anti-p17 antibodies which specifically recognize said neutralizing epitope

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62164696A (ja) * 1986-01-06 1987-07-21 エフ.ホフマン ― ラ ロシュ アーゲー HTLV−3gag遺伝子の発現
NZ220200A (en) * 1986-05-19 1990-08-28 Viral Technologies Inc Hiv related peptides, antibodies to the peptides and vaccines therefrom
EP0273716B1 (en) * 1986-12-30 1993-08-11 THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce Synthetic peptides which induce cellular immunity to the aids virus and aids viral proteins
NO881151L (no) * 1987-03-27 1988-09-28 Syntello Ab Syntetisk hiv-1-antigen.
DK643188A (da) * 1987-11-24 1989-05-25 Smithkline Biolog Ekspression af hiv-proteiner i e.coli og s.cerevisiae
EP0330359A3 (en) * 1988-02-25 1991-06-05 Bio-Rad Laboratories, Inc. Composition useful in the diagnosis and treating of hiv-1 infection

Also Published As

Publication number Publication date
HU906421D0 (en) 1991-04-29
HUT55035A (en) 1991-04-29
CN1052310A (zh) 1991-06-19
DE69017352T2 (de) 1995-10-05
AU6393990A (en) 1991-04-18
EP0426314A2 (en) 1991-05-08
GR3015244T3 (en) 1995-06-30
EP0426314A3 (en) 1991-07-24
GB2236754A (en) 1991-04-17
ES2071038T3 (es) 1995-06-16
EP0620010A1 (en) 1994-10-19
ZA907944B (en) 1991-10-30
EP0426314B1 (en) 1995-03-01
CA2027455A1 (en) 1991-04-13
DK0426314T3 (da) 1995-03-27
IE67533B1 (en) 1996-04-03
ATE119166T1 (de) 1995-03-15
DE69017352D1 (de) 1995-04-06
NZ235538A (en) 1992-06-25
IE903604A1 (en) 1991-04-24
KR910007962A (ko) 1991-05-30
GB9021942D0 (en) 1990-11-21
JPH03209398A (ja) 1991-09-12
EP0620009A1 (en) 1994-10-19

Similar Documents

Publication Publication Date Title
ATE373010T1 (de) Gag-antigen und dessen verwendung zum nachweis von lav-infektion, sowie in immunogenen zusammensetzungen
DE60026332D1 (de) Diagnose von einheimischer sprue/zöliakie mit hilfe von gliadinepitopen
ES2013346A6 (es) Metodos para producir secuencias y moleculas de adn recombinante, asi como proteinas t4 solubles.
AU1353295A (en) Peptides derived from a retrovirus of the HIV group, and their use
DE68928130D1 (de) Synthetische vom HIV-GP120-env-Protein abgeleitete Peptide und ihre Anwendung
IL152507A0 (en) Methods and compositions for impairing multiplication of hiv-1
WO1991009872A3 (en) Hiv-1 env fragment fusion protein
IL95742A0 (en) Recombinant polypeptides and peptides,nucleic acids coding for the same and use of these polypeptides and peptides in the diagnosis of tuberculosis
US4755380A (en) Peptide from amyloid A and antiserum therefor
EP0426314A3 (en) Hiv related peptides
EP0177814A3 (en) Peptide antibodies and their use in detecting oncogene products
EP0330700A4 (en) Human prourokinase-like polypeptide.
DE69012989D1 (de) Peptiden von retinblastoma gen produkten und antikoerper dagegen.
GB2299994B (en) Equine arteritis virus peptides; antibodies and their use in a diagnostic test
PT87239A (pt) Process for the preparation of peptides
TH9844A (th) เพพไทด์ที่สัมพันธุ์ hiv
HUP9900766A2 (hu) Helicobacter pylorival kapcsolatos nukleinsav- és aminosavszekvenciák diagnosztikumokhoz és gyógyszerekhez
TH9844EX (th) เพพไทด์ที่สัมพันธุ์ hiv